These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Congenital Myasthenic Syndromes in 2018. Engel AG Curr Neurol Neurosci Rep; 2018 Jun; 18(8):46. PubMed ID: 29892917 [TBL] [Abstract][Full Text] [Related]
29. A severe congenital myasthenic syndrome with "dropped head" caused by novel MUSK mutations. Giarrana ML; Joset P; Sticht H; Robb S; Steindl K; Rauch A; Klein A Muscle Nerve; 2015 Oct; 52(4):668-73. PubMed ID: 25900532 [TBL] [Abstract][Full Text] [Related]
30. A homozygous mutation in GMPPB leads to centronuclear myopathy with combined pre- and postsynaptic defects of neuromuscular transmission. Nicolau S; Liewluck T; Shen XM; Selcen D; Engel AG; Milone M Neuromuscul Disord; 2019 Aug; 29(8):614-617. PubMed ID: 31378432 [TBL] [Abstract][Full Text] [Related]
31. A late-onset congenital myasthenic syndrome due to a heterozygous DOK7 mutation. Bastos P; Barbosa R; Fernandes M; Alonso I Neuromuscul Disord; 2020 Apr; 30(4):331-335. PubMed ID: 32360404 [TBL] [Abstract][Full Text] [Related]
32. Respiratory insufficiency as a presenting symptom of congenital myasthenic syndromes. van den Udenhout F; Merkus P; Verhaagen-van den Akker S; Schouten M; Erasmus C; Braakman H Acta Paediatr; 2023 May; 112(5):1091-1096. PubMed ID: 36718955 [TBL] [Abstract][Full Text] [Related]
34. Variants in SLC18A3, vesicular acetylcholine transporter, cause congenital myasthenic syndrome. O'Grady GL; Verschuuren C; Yuen M; Webster R; Menezes M; Fock JM; Pride N; Best HA; Benavides Damm T; Turner C; Lek M; Engel AG; North KN; Clarke NF; MacArthur DG; Kamsteeg EJ; Cooper ST Neurology; 2016 Oct; 87(14):1442-1448. PubMed ID: 27590285 [TBL] [Abstract][Full Text] [Related]
35. [Congenital myasthenic syndromes. Clinical and electromyographic evaluation]. Martin Santidrian MA; Prats Viñas JM; Garaizar Axpe C; Ruiz Espinosa C An Esp Pediatr; 2002 Jan; 56(1):10-6. PubMed ID: 11792263 [TBL] [Abstract][Full Text] [Related]
36. Variants of Lamond A; Buckley D; O'Dea J; Turner L BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33462016 [TBL] [Abstract][Full Text] [Related]
37. A Missense Mutation in Epsilon-subunit of Acetylcholine Receptor Causing Autosomal Dominant Slow-channel Congenital Myasthenic Syndrome in a Chinese Family. Tan JZ; Man Y; Xiao F Chin Med J (Engl); 2016 Nov; 129(21):2596-2602. PubMed ID: 27779167 [TBL] [Abstract][Full Text] [Related]
38. Congenital myasthenic syndrome: a brief review. Lorenzoni PJ; Scola RH; Kay CS; Werneck LC Pediatr Neurol; 2012 Mar; 46(3):141-8. PubMed ID: 22353287 [TBL] [Abstract][Full Text] [Related]
39. Biallelic loss of function variants in SYT2 cause a treatable congenital onset presynaptic myasthenic syndrome. Donkervoort S; Mohassel P; Laugwitz L; Zaki MS; Kamsteeg EJ; Maroofian R; Chao KR; Verschuuren-Bemelmans CC; Horber V; Fock AJM; McCarty RM; Jain MS; Biancavilla V; McMacken G; Nalls M; Voermans NC; Elbendary HM; Snyder M; Cai C; Lehky TJ; Stanley V; Iannaccone ST; Foley AR; Lochmüller H; Gleeson J; Houlden H; Haack TB; Horvath R; Bönnemann CG Am J Med Genet A; 2020 Oct; 182(10):2272-2283. PubMed ID: 32776697 [TBL] [Abstract][Full Text] [Related]
40. Slow-Channel Congenital Myasthenic Syndrome due to a Novel Mutation in the Acetylcholine Receptor Alpha Subunit in a South Asian: A Case Report. Gooneratne IK; Nandasiri S; Maxwell S; Webster R; Cossins J; Beeson D; Gunaratne K; Herath L; Senanayake S; Chang T J Neuromuscul Dis; 2021; 8(1):163-167. PubMed ID: 33216040 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]